Steadview Capital makes partial exit from bulk drugs firm

Alternative investment firm Steadview Capital has made back-to-back partial exits from portfolio companies taking advantage of the buoyant stock market valuations with the latest being one from a two-year-old investment in an active pharmaceutical ingredients (API) maker.  Steadview Capital, along with its affiliates, has sold about half a million shares through ......